Biotricity Performance
The firm shows a Beta (market volatility) of 0.15, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Biotricity's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biotricity is expected to be smaller as well. Biotricity right now shows a risk of 0.0%. Please confirm Biotricity variance and skewness , to decide if Biotricity will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Biotricity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Biotricity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 570.5 K |
Biotricity |
Biotricity Relative Risk vs. Return Landscape
If you would invest (100.00) in Biotricity on September 2, 2024 and sell it today you would earn a total of 100.00 from holding Biotricity or generate -100.0% return on investment over 90 days. Biotricity is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Biotricity, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biotricity Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotricity's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biotricity, and traders can use it to determine the average amount a Biotricity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BTCY |
Based on monthly moving average Biotricity is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biotricity by adding Biotricity to a well-diversified portfolio.
Biotricity Fundamentals Growth
Biotricity Stock prices reflect investors' perceptions of the future prospects and financial health of Biotricity, and Biotricity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biotricity Stock performance.
| Return On Equity | -41.01 | ||||
| Return On Asset | -0.89 | ||||
| Profit Margin | (1.17) % | ||||
| Operating Margin | (0.96) % | ||||
| Current Valuation | 38.87 M | ||||
| Shares Outstanding | 21.48 M | ||||
| Price To Earning | (6.70) X | ||||
| Price To Book | 33.02 X | ||||
| Price To Sales | 0.83 X | ||||
| Revenue | 12.06 M | ||||
| EBITDA | (8.82 M) | ||||
| Cash And Equivalents | 2.89 M | ||||
| Cash Per Share | 0.05 X | ||||
| Total Debt | 23.88 M | ||||
| Debt To Equity | 6.45 % | ||||
| Book Value Per Share | (3.31) X | ||||
| Cash Flow From Operations | (6.69 M) | ||||
| Earnings Per Share | (1.66) X | ||||
| Total Asset | 5.94 M | ||||
| Retained Earnings | (127.5 M) | ||||
| Current Asset | 11 K | ||||
| Current Liabilities | 303 K | ||||
About Biotricity Performance
Evaluating Biotricity's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Biotricity has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biotricity has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. Biotricity operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 44 people.Things to note about Biotricity performance evaluation
Checking the ongoing alerts about Biotricity for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biotricity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biotricity is not yet fully synchronised with the market data | |
| Biotricity has some characteristics of a very speculative penny stock | |
| Biotricity has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.06 M. Net Loss for the year was (14.09 M) with profit before overhead, payroll, taxes, and interest of 4.57 M. | |
| Biotricity currently holds about 2.89 M in cash with (6.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. | |
| Roughly 49.0% of the company shares are held by company insiders |
- Analyzing Biotricity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biotricity's stock is overvalued or undervalued compared to its peers.
- Examining Biotricity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biotricity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biotricity's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biotricity's stock. These opinions can provide insight into Biotricity's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Biotricity Stock
If you are still planning to invest in Biotricity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotricity's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |